MetaCap

Philip Morris International Earnings

NYSE: PMHealth Care Medicinal Chemicals and Botanical Products USD

200.16-0.34 (-0.17%)

Market open · Delayed 15 min · as of Oct 9, 3:23 PM ET

Next earnings date

Tue, Oct 20, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$2.33

Philip Morris International earnings summary

Philip Morris International is scheduled to report Sep/2026 earnings on Oct 20, 2026 before the market opens, with analysts expecting EPS of $2.33. In its most recent report on Jul 24, 2026 (Q2 2026), PM posted EPS of $1.80. Revenue for the quarter was $11.19 billion.

Quarterly EPS is down 7.7% from the same quarter a year earlier. Across the last 16 reports, PM shares moved an average of 2.7% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.

Summary generated from market data by MetaCap's automated system. Methodology

PM earnings history

Philip Morris International reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 24, 2026—$1.80—-1.1%
Apr 24, 2026—$1.56—+1.3%
Feb 6, 2026—$1.36—+2.6%
Oct 24, 2025—$2.23—-8.4%
Jul 25, 2025—$1.95—+1.3%
Apr 24, 2025—$1.72—+0.4%
Feb 6, 2025—$-0.37—+4.2%
Oct 24, 2024—$1.97—+0.6%
Jul 25, 2024—$1.54—+3.9%
Apr 26, 2024—$1.38—+2.5%
Feb 8, 2024—$1.41—+0.6%
Oct 26, 2023—$1.32—+4.6%
Jul 27, 2023—$1.01—-3.7%
Apr 26, 2023—$1.28—-4.4%
Feb 10, 2023—$1.54—-0.5%
Oct 27, 2022—$1.34—-2.8%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related